Neuralisse Review: Nerve Claims vs the Evidence

Key takeaways

• Neuralisse is sold through a checkout-style order page with almost no sales copy. Its entire pitch is on the bottle label: "Neuropathy Support Formula" with claims of nerve health, comfort support, and nutritional support.
• The full Supplement Facts panel is visible, which is more transparent than most pages we review. It lists 80 mg of magnesium and a 575 mg proprietary blend of six ingredients, with no individual doses disclosed.
• The blend math fails. The best-studied nerve ingredient in the blend, alpha-lipoic acid, was tested at 600 mg per day. The entire blend is 575 mg, so no ingredient in it can reach a studied dose.
• A certification graphic on the page displays an "FDA APPROVED" badge, even though the page's own footer states that the FDA has not evaluated these statements. The FDA does not approve dietary supplements.
• The legal pages name "Vigorus" as the site owner and "Group Elevate" as an assignee, with fulfillment by SHIPOFFERS and retailing by BuyGoods. No further company identity is given.
• Pricing is open: $79, $69, or $49 per bottle depending on package (about $1.63 to $2.63 per day), with a 60-day guarantee that requires you to return all bottles at your own shipping cost.

Contents

• The short verdict
• What the page actually is
• The label, read in full
• The blend math problem
• The "FDA approved" badge vs the page's own footer
• Who is actually behind this
• The price math
• The guarantee fine print
• What older adults should know
• Regulatory check
• Sources

The short verdict

Neuralisse is a capsule supplement marketed for nerve health, sold through a checkout-style order page. We reviewed the page in full on October 11, 2026, including every footer legal page.

This page is more transparent than most in one way: it shows the actual Supplement Facts panel. And that panel is exactly what sinks it. The 575 mg proprietary blend cannot contain any ingredient at a studied dose, because the studied doses are larger than the whole blend. The marketing is quiet, but the label does the talking, and the label does not add up.

The page also carries an "FDA APPROVED" badge that contradicts its own footer, and the company behind it is effectively unnamed. For a product aimed at people with nerve symptoms, these are not small details.

What the page actually is

Unlike the long sales letters we usually tear down, this Neuralisse page is a bare order page: "Step 1: Select Your Discount Package," pricing tiers, a guarantee section, and a footer. There is no story, no doctor persona, no testimonials, no countdown timer, no cited studies.

The only health claims on the page are the ones printed on the bottle itself: "NEUROPATHY SUPPORT FORMULA," with label bullets for "NERVE HEALTH," "COMFORT SUPPORT," and "NUTRITIONAL SUPPORT," taken once daily. The page deserves credit for what it does not do. There are no before-and-after photos, no "clinically proven" language, no percentage-improvement claims, and no disease-cure promises.

But minimal marketing is not the same as an honest product. The label makes structure and function claims, and those claims need to be checked against the label's own numbers.

The label, read in full

The Supplement Facts panel on the page reads:

• Serving size: 1 capsule. Servings per container: 30. Suggested use: one capsule daily.
• Magnesium (as magnesium glycinate, from the proprietary blend): 80 mg, 19% of the Daily Value.
• Proprietary blend: 575 mg. Magnesium glycinate, alpha-lipoic acid, butcher's broom root extract, L-carnitine, turmeric rhizome extract (95% curcuminoids), coenzyme Q10 (as ubiquinone). Individual component doses are not broken out.
• Other ingredients: hypromellose (vegetable capsule), microcrystalline cellulose, magnesium stearate, stearic acid, silicon dioxide.
• Distributed by: Neuralisse, Aurora, CO 80011, USA, with phone +1 (323) 403-4725.

Showing the full panel is genuinely better than the pages that disclose nothing. But a proprietary blend with no per-ingredient doses still hides the one number that matters: how much of each ingredient you actually get.

The blend math problem

Six ingredients share 575 mg. That is the entire dose budget. Now compare it with what the research actually tested:

This is the decisive point. Alpha-lipoic acid is the best-studied supplement for nerve symptoms, and the NCCIH notes it "might be helpful" for diabetic neuropathy pain while cautioning that studies are small and inconsistent. But the evidence required 600 mg a day. This product's entire blend is 575 mg. The math rules out an effective dose before the first capsule is swallowed.

The same applies to the carnitine research, which used the acetylated form (acetyl-L-carnitine) at gram-level doses, not the plain L-carnitine named on this label. Butcher's broom has its evidence base in chronic venous insufficiency (leg veins), not nerve health, and even there the European Medicines Agency concluded the benefit was not convincing and its conclusions rest on traditional use, not trials.

When a blend hides every dose, the generous assumption is that each ingredient is present in a token amount. Nothing on this label contradicts that assumption.

Readers who want the pattern in context can compare our teardowns of Jellutide and Sodaboost, where proprietary blends and bold label claims followed the same playbook.

The "FDA approved" badge vs the page's own footer

A certification graphic on the page displays four badges: GMP, "FDA APPROVED," "MADE IN USA," and "GMO FREE." One of these is false.

The FDA does not approve dietary supplements, their labels, or their manufacturing facilities before they are sold. A federal warning letter to another supplement seller put it plainly: "FDA does not approve dietary supplement manufacturing facilities," calling such statements false or misleading. The same logic applies to a product badge.

What makes this worse is that the page contradicts itself. The footer on the very same page states: "Statements on this website have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease." All four legal pages repeat that the information "has not been evaluated by any regulatory authority."

A badge cannot claim FDA approval on the same page whose footer says the FDA has not evaluated the statements. One of them is wrong, and the footer is the one telling the truth.

Who is actually behind this

The legal pages were read in full. Here is what they reveal, and what they do not:

• The brand: Neuralisse. The label gives a distributor address of Aurora, CO 80011, which matches the SHIPOFFERS fulfillment warehouse address, not a company headquarters.
• The operator: the Terms of Service state that site content "is the property of Vigorus or its licensors," and the Disclaimer repeatedly names Vigorus. "Group Elevate" is named once as an assignee of the agreement. No further company name, registration, or address is given anywhere in these pages.
• The retailer: BuyGoods, described as a Delaware corporation at 1201 N Orange Street Suite #7223, Wilmington, DE 19801. The page states BuyGoods' role "does not constitute an endorsement, approval or review of this product or any claim."
• Contact: phone +1 (323) 403-4725 and [email protected]. No named individuals.

So the chain is: a brand with no company behind it, operated (per its own legal pages) by "Vigorus," fulfilled from a third-party warehouse, and retailed through a separate Delaware corporation. If you have a problem with the product, the refund process runs through this chain, not a single accountable company. That is worth knowing before you pay.

The price math

Pricing is displayed openly, which we credit. Three tiers, all one-time purchases with no subscription or auto-ship:

Each tier is anchored against a struck-through "regular" price ($358, $537, $1,074), implying a per-bottle regular price of about $179 and claimed savings of $200 to $780. Those anchor prices have no documented sales history. They are a pricing tactic.

Shipping pressure is built into the tiers: the 2-bottle package adds shipping, while the 3- and 6-bottle packages ship free. The 6-bottle tier is presented as "Best Value," but its 180-day supply sits awkwardly against the 60-day guarantee window. Buy six bottles and your refund window closes four months before you finish them.

The guarantee fine print

The guarantee is a 60-day money-back promise from the date of purchase. The Return Policy page spells out the process:

• Contact the support team for return instructions before sending anything back.
• Return all bottles, empty or not, with the packing slip, to the Aurora, CO warehouse, with a note including your full name, email, and order ID.
• You pay all return shipping, and the original shipping fees are non-refundable.
• The refund is processed only after the package is received and inspected, and takes 5-10 business days to appear on your original payment method.

Empty bottles are accepted, which is fair. But there is no RMA system mentioned, and the whole process depends on email support from an unnamed company. With no independent reviews of the refund experience, the guarantee is a promise on paper only.

What older adults should know

Nerve symptoms in older adults deserve a diagnosis first. Tingling and numbness can come from diabetes, vitamin B12 deficiency, thyroid problems, circulation issues, or medications. The NIH notes that B12 deficiency affects a meaningful share of older adults and that a doctor can test for it directly. If deficiency is the cause, treatment is straightforward. If it is not, no supplement fixes it.

• Do not dose in the dark. The undisclosed blend doses mean you cannot check interactions properly. Alpha-lipoic acid can lower blood sugar, which matters if you take diabetes medications. Butcher's broom has alpha-adrenergic activity, which can theoretically interact with blood pressure drugs. Without doses, your pharmacist cannot assess either risk.
• The magnesium is modest and safe. At 80 mg, it is well under the NIH's 350 mg daily upper limit for magnesium from supplements. Our magnesium guide covers safe ranges.
• Do not skip proven care. The NCCIH warns explicitly against replacing medical treatment for diabetes or its complications with unproven products. Nerve pain has effective medical treatments, and the evidence for this product's formula at these unknown doses is, at best, a fraction of a studied dose.

Talk to your doctor or pharmacist before trying any nerve supplement, especially if you take diabetes medications, blood pressure drugs, or blood thinners.

Regulatory check

As of October 11, 2026, we found no FDA warning letter, FDA enforcement action, or FTC action naming Neuralisse, Vigorus, or Group Elevate. The absence of an action is not an endorsement. It means regulators have not publicly acted.

For context: the FTC has permanently banned supplement sellers from the industry over unsubstantiated claims that products treat or cure diabetic neuropathy, including its 2022 order against Health Research Laboratories and its owner. And the FDA has called "FDA approved" facility claims for supplements false or misleading. The badge on this page sits squarely in that territory.

Sources

• NCCIH: Diabetes and Dietary Supplements, What You Need To Know (alpha-lipoic acid evidence for neuropathy pain; studies small and inconsistent; do not replace medical treatment)
• Nutraceutical supplementation and neuropathic pain review, PMC (ALA trial evidence, including SYDNEY 2 at 600 mg/day)
• Acetyl-L-carnitine in painful peripheral neuropathy, systematic review, PMC (trial doses 1,000-3,000 mg/day)
• NIH Office of Dietary Supplements: Vitamin B12 Fact Sheet for Consumers (deficiency causes numbness and tingling; common in older adults; a doctor can test)
• NIH Office of Dietary Supplements: Magnesium Fact Sheet for Consumers (adult upper limit 350 mg/day from supplements)
• NCCIH: Coenzyme Q10
• Mayo Clinic: Coenzyme Q10 (interactions, including blood thinners)
• European Medicines Agency: Butcher's Broom Summary for the Public (benefit "not convincing"; conclusions based on traditional use)
• FDA Warning Letter: Fibromyalgia Treatment Group ("FDA does not approve dietary supplement manufacturing facilities"; such claims are false or misleading)
• FTC: Final Order Banning Deceptive Marketing by Supplement Seller (unsubstantiated neuropathy cure claims)

The product page and its legal pages were reviewed in full on October 11, 2026. The page URL is research material and is not published here.

Fact-checked by the SupplementDecoded Research Editorial Team